Sartorius (OTCMKTS:SARTF) Sees Significant Decline in Short Interest

Sartorius (OTCMKTS:SARTF – Get Free Report) saw a large decline in short interest during the month of October. As of October 30th, there was short interest totaling 836 shares, a decline of 54.2% from the October 15th total of 1,827 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days. Currently, 0.0% of the company’s stock are sold short.

Sartorius Price Performance

Shares of SARTF remained flat at $261.99 during trading on Friday. The business has a fifty day simple moving average of $241.61 and a two-hundred day simple moving average of $224.03. Sartorius has a 52 week low of $181.58 and a 52 week high of $261.99. The firm has a market capitalization of $8.97 billion, a PE ratio of 121.85 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95.

About Sartorius

(Get Free Report)

Sartorius is a life science company headquartered in Göttingen, Germany. Founded in 1870 as a precision-balance manufacturer, it has grown into a global supplier of technologies and services for biopharmaceutical production and laboratory research. The company’s bioprocessing products include filtration and fluid-management systems, single-use equipment, bioreactors, and technologies used in cell culture and purification. These solutions support the development and manufacture of biologic medicines, including vaccines and other advanced therapies.

See Also

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.